Most women diagnosed with breast cancer today live many years, and for early‑stage disease the 5‑year survival rate is extremely high, around 99% or more in high‑income countries.

Quick Scoop

  • Overall, breast cancer has one of the highest cancer survival rates, especially when it is found early.
  • For cancer that is only in the breast (localized, early stage), the 5‑year relative survival rate in the U.S. is over 99%.
  • When cancer has spread to nearby lymph nodes (regional), 5‑year survival is usually in the 80–90% range, depending on details like tumor biology and treatment.
  • When it has spread to distant organs (metastatic, stage 4), 5‑year survival drops significantly—often around 30% on average—though some people live much longer with modern treatments.
  • Survival rates keep improving over time because of better screening, targeted therapy, hormonal therapy, and immunotherapy.

What “5‑year relative survival” means

“5‑year relative survival” compares people with breast cancer to similar people in the general population.
If the 5‑year relative survival is 99%, it means people with that stage of breast cancer are almost as likely to be alive 5 years later as people without cancer.

Typical stage‑based 5‑year survival (U.S., recent data)

These are rounded ranges for adults with invasive breast cancer; exact numbers vary slightly by source and year.

  • Stage I (very early): about 99–100%
  • Stage II: roughly high‑80s to mid‑90s%
  • Stage III: roughly mid‑60s to high‑80s/90s% (depends on how extensive it is)
  • Stage IV (metastatic): often around 30% on average, with a wide range between individuals

What affects an individual’s outlook

Survival rate is an average; it cannot predict what will happen to any one person.

Key factors that change prognosis include:

  • Stage at diagnosis (how far it has spread)
  • Tumor type and biology (hormone receptor‑positive, HER2‑positive, triple‑negative, etc.)
  • Age and overall health
  • Treatments received (surgery, radiation, chemo, hormone therapy, targeted therapy, immunotherapy)

Many people with early‑stage breast cancer are treated and never have it come back, and even for metastatic disease, newer therapies are helping people live longer and with better quality of life.

If this question is about you or someone close to you, the most important step is to ask the treating oncologist to explain the stage, subtype, and personalized outlook; they can translate these broad statistics into what they mean for that specific situation.

Information gathered from public forums or data available on the internet and portrayed here.